SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001144204-19-007765
Filing Date
2019-02-14
Accepted
2019-02-14 11:26:02
Documents
3

Document Format Files

Seq Description Document Type Size
1 F-1/A tv513608_f1a.htm F-1/A 525938
2 EXHIBIT 23.1 tv513608_ex23-1.htm EX-23.1 3172
3 EXHIBIT 23.2 tv513608_ex23-2.htm EX-23.2 3375
  Complete submission text file 0001144204-19-007765.txt   533651
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: F-1/A | Act: 33 | File No.: 333-227752 | Film No.: 19602856
SIC: 2834 Pharmaceutical Preparations